Education
About Us
Working with TipRanks
Follow Us
vTv Therapeutics (VTVT)
NASDAQ:VTVT
VTVT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$12.12 - $29.19
Previous CloseN/A
Volume611.00
Average Volume (3M)36.67K
Market Cap
$56.15M
Enterprise Value$35.56M
Total Cash (Recent Filing)$1.68M
Total Debt (Recent Filing)$15.71M
Price to Earnings (P/E)―
Beta0.79
Next Earnings
May 08, 2025EPS Estimate
-0.9Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.41
Shares Outstanding2,612,257
10 Day Avg. Volume82,934
30 Day Avg. Volume36,666
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)56.15
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-2.62
Enterprise Value/Ebitda-1.60
Forecast
1Y Price Target
$35.00Price Target Upside110.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
vTv Therapeutics News
PremiumCompany Announcements
vTv Therapeutics CFO Steven Tuch to ResignPremiumCompany Announcements
vTv Therapeutics Highlights Progress on Diabetes Treatment---
Ownership Overview
19.44% Insiders
8.77% Mutual Funds
11.64% Other Institutional Investors
58.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VTVT FAQ
What was vTv Therapeutics’s price range in the past 12 months?
vTv Therapeutics lowest stock price was $12.12 and its highest was $29.19 in the past 12 months.
What is vTv Therapeutics’s market cap?
vTv Therapeutics’s market cap is $56.15M.
When is vTv Therapeutics’s upcoming earnings report date?
vTv Therapeutics’s upcoming earnings report date is May 08, 2025 which is in 45 days.
How were vTv Therapeutics’s earnings last quarter?
vTv Therapeutics released its earnings results on Mar 20, 2025. The company reported -$0.55 earnings per share for the quarter, beating the consensus estimate of -$0.87 by $0.32.
Is vTv Therapeutics overvalued?
According to Wall Street analysts vTv Therapeutics’s price is currently Undervalued.
Does vTv Therapeutics pay dividends?
vTv Therapeutics does not currently pay dividends.
What is vTv Therapeutics’s EPS estimate?
vTv Therapeutics’s EPS estimate is -0.9.
How many shares outstanding does vTv Therapeutics have?
vTv Therapeutics has 2,612,257 shares outstanding.
What happened to vTv Therapeutics’s price movement after its last earnings report?
vTv Therapeutics reported an EPS of -$0.55 in its last earnings report, beating expectations of -$0.87. Following the earnings report the stock price went down -5.455%.
Which hedge fund is a major shareholder of vTv Therapeutics?
Currently, no hedge funds are holding shares in VTVT
---
vTv Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$35.00 (110.34% Upside)
$35.00 (110.34% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 9.7%
Last 30 Days ▼ 9.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-42.62%
12-Months-Change
Fundamentals
Return on Equity
-121.97%
Trailing 12-Months
Asset Growth
247.30%
Trailing 12-Months
Company Description
vTv Therapeutics
vTv Therapeutics (VTVT) is a clinical-stage biopharmaceutical company focused on the discovery and development of orally administered small molecule drug candidates. The company primarily operates in the pharmaceutical and biotechnology sectors, with a core emphasis on developing therapeutic solutions for metabolic diseases, including diabetes and inflammatory disorders. vTv Therapeutics leverages its proprietary technology platform, TTP Translational Technology, to advance its pipeline of innovative drug candidates.
---
VTVT Stock 12 Month Forecast
Average Price Target
$35.00
▲(110.34% Upside)
Technical Analysis
Best Analysts Covering VTVT
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-16.00%
reiterated a buy rating 3 days ago
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.00% per trade.
---